WHY WE EXIST

At Melanoma UK, we believe it is vital to proactively use evidence in our advocacy work.

An increasing proportion of patients are highly sophisticated in their research and understanding of evidence, and we are matching this movement. Examples include participation in health technology appraisal meetings (NICE and SMC), presenting clinically validated information on our website, authoring publications from our Melanoma UK digital registry, engaging with our own panel of medical experts, and using our registry data to support patient-centric initiatives, such as targeting travel grants where they are most needed.

Ultimately, all these initiatives are designed to benefit and support patients, which has been Melanoma UK's mission since its foundation.

Latest

WHAT A DIFFERENCE A YEAR MAKES

This time a year ago, we had just held our first Zoom support call. We didn’t think for a moment that the following year, we would still be in some form of lockdown and still holding our patient calls.
NON MELANOMA SKIN CANCER REPORT

UK report highlights the low awareness of non-melanoma skin cancer and its true impact on patients and the health system.
FULL WORM MOON

This month’s full moon is not only the first ‘Super Moon’ of 2021, but the first full moon of Spring, hence its nickname, ‘Worm Moon’, heralding the warmer days and the stirring of life beneath our feet.
MELANOMA PATIENTS MATTER REPORT

Improving communication and support for patients during treatment and care

ME MELANOMA, NO CHANCE!

My Melanoma Journey as written by Jayne Williams
UNIVERSITY OF MANCHESTER MELANOMA PROJECT

The University of Manchester is carrying out research project looking into improving patient responses to immunotherapy.
MELANOMA SKIN CANCER AWARENESS MONTH

May is Melanoma Awareness Month and we want to encourage more people to get into a habit and do regular monthly skin self-examinations.
ROADMAP FOR PATIENTS CURRENTLY SHIELDING

The UK Government has set out a roadmap for the clinically extremely vulnerable on the future of the shielding programme.
MEMORIAL SERVICE PROFESSOR MARTIN GORE CBE

In 2007 when our Founder Gill Nuttall, was looking for some help for Jon,Professor Gore was one of the first people she contacted.
MARK WATSON SHARES HIS FIGHT WITH MELANOMA

Mark Watson shares his story about his battle with melanoma. This is his story so far as told by Mark.
COVID 19 - UPDATE

Melanoma UK is still receiving calls and emails regarding the virus.
LISA COSTELLO JOINS OUR AMBASSADOR PROGRAM

A big shout out for our very own pocket rocket Lisa Costello who joins the team.
SIGNS AND SYMPTOMS

About half of all melanomas start with a change in previously normal-looking skin. This usually looks like a dark area or an abnormal new mole.
MELANOMA SKIN CANCER DRUG RECOMMENDED FOR ROUTINE NHS USE

NICE recommends the routine use of nivolumab as an option after surgery for some people with melanoma.